These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14087164)

  • 1. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract]   [Full Text] [Related]  

  • 2. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 3. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 5. ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
    ABRAMSON HA
    J Asthma Res; 1964 Mar; 1(3):207-11. PubMed ID: 14135439
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 8. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 9. [INTRAVASCULAR ERYTHROCYTE AGGREGATION AND D-1 METHYL-LYSERGIC ACID BUTANOLAMIDE (DESERRIL OR UML 491)].
    PIOVELLA C; DESILVESTRI A
    Cuore Circ; 1963 Aug; 47():179-85. PubMed ID: 14084723
    [No Abstract]   [Full Text] [Related]  

  • 10. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methysergide and x-irradiation on the barbiturate sleeping-time in rats.
    VARAGIC V; STEPANOVIC S; HAJDUKOVIC S
    Int J Radiat Biol Relat Stud Phys Chem Med; 1962 Oct; 5():559-65. PubMed ID: 13996273
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modifications of the EEG and the photosensitivity of Papio papio under the effect of different derivatives of ergot].
    Balzano E; Meldrum BS; Naquet R; Vuillon-Cacciuttolo G
    Rev Electroencephalogr Neurophysiol Clin; 1971; 1(2):219-30. PubMed ID: 5006269
    [No Abstract]   [Full Text] [Related]  

  • 14. Appraisal of methysergide in treatment of vascular headaches of migraine type.
    FRIEDMAN AP; ELKIND AH
    JAMA; 1963 Apr; 184():125-8. PubMed ID: 13959785
    [No Abstract]   [Full Text] [Related]  

  • 15. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
    FISCHER R
    Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mass spectrometry of ergot alkaloids].
    Voigt D; Johne S; Gröger D
    Pharmazie; 1974; 29(10-11):697-700. PubMed ID: 4438411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychological and biochemical effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    Nature; 1951 Nov; 168(4280):827-8. PubMed ID: 14890764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with the use of alkanolamides of lysergic acid in clinical obstetrics].
    WOLLMANN H
    Z Geburtshilfe Gynakol; 1950; 134(1):109-23. PubMed ID: 14810077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.